The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2015

Filed:

Jul. 25, 2008
Applicants:

Dilip Narayanrao Bhedi, Mumbai, IN;

Ram Asrey Vishwakarma, Jammu & Kashmir, IN;

Vaishali Deka, Mumbai, IN;

Dattatray Maruti More, Dist-Pune, IN;

Manivannan Ramalingam, Tamilnadu, IN;

Ashish Suthar, Mumbai, IN;

Roda Dalal, Mumbai, IN;

Sapna Parikh, Mumbai, IN;

Aditi Amol Tannu, Mumbai, IN;

Inventors:

Dilip Narayanrao Bhedi, Mumbai, IN;

Ram Asrey Vishwakarma, Jammu & Kashmir, IN;

Vaishali Deka, Mumbai, IN;

Dattatray Maruti More, Dist-Pune, IN;

Manivannan Ramalingam, Tamilnadu, IN;

Ashish Suthar, Mumbai, IN;

Roda Dalal, Mumbai, IN;

Sapna Parikh, Mumbai, IN;

Aditi Amol Tannu, Mumbai, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/541 (2006.01); C07D 307/92 (2006.01); C07D 405/06 (2006.01); C07D 413/06 (2006.01); C07D 417/06 (2006.01); A61K 31/343 (2006.01); A61K 31/496 (2006.01); A61K 31/4525 (2006.01); A61K 31/4155 (2006.01); A61K 31/4178 (2006.01); A61K 31/4196 (2006.01); A61K 31/4025 (2006.01); A61K 31/5377 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01); A61P 19/10 (2006.01); A61P 9/00 (2006.01); A61P 17/06 (2006.01); A61P 37/04 (2006.01); A61P 37/06 (2006.01); A61P 37/02 (2006.01); A61P 25/28 (2006.01); A61P 31/18 (2006.01); A61P 11/00 (2006.01); A61P 31/14 (2006.01); A61P 3/10 (2006.01); A61P 11/06 (2006.01); A61P 35/00 (2006.01); C07D 405/12 (2006.01); C07H 17/04 (2006.01);
U.S. Cl.
CPC ...
C07D 307/92 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 417/06 (2013.01); C07H 17/04 (2013.01);
Abstract

The present invention provides compounds represented by formula I: wherein, R, R, R, R, R, R, R, R, R, R, R, R, Rand X are as defined in the specification, in all its stereoisomeric and tautomeric forms and mixtures thereof in all ratios, and its pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable polymorphs and prodrugs. These compounds are useful for treatment of inflammatory disorders including those caused by elevated levels of proinflammatory cytokines such as Tumor Necrosis Factor (TNF-α and/or interleukins (IL-1β, IL-6, IL-8). The invention also relates to processes for the manufacture of compounds of formula 1 and pharmaceutical compositions containing them.


Find Patent Forward Citations

Loading…